JANX
Price
$28.84
Change
-$0.18 (-0.62%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
1.75B
107 days until earnings call
Intraday BUY SELL Signals
KYMR
Price
$64.92
Change
+$0.61 (+0.95%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
4.67B
92 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

JANX vs KYMR

Header iconJANX vs KYMR Comparison
Open Charts JANX vs KYMRBanner chart's image
Janux Therapeutics
Price$28.84
Change-$0.18 (-0.62%)
Volume$5.68K
Capitalization1.75B
Kymera Therapeutics
Price$64.92
Change+$0.61 (+0.95%)
Volume$10.2K
Capitalization4.67B
JANX vs KYMR Comparison Chart in %
JANX
Daily Signal:
Gain/Loss:
KYMR
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
JANX vs. KYMR commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JANX is a Hold and KYMR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (JANX: $29.02 vs. KYMR: $64.38)
Brand notoriety: JANX and KYMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: JANX: 66% vs. KYMR: 48%
Market capitalization -- JANX: $1.73B vs. KYMR: $4.67B
JANX [@Biotechnology] is valued at $1.73B. KYMR’s [@Biotechnology] market capitalization is $4.67B. The market cap for tickers in the [@Biotechnology] industry ranges from $106.82B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

JANX’s FA Score shows that 0 FA rating(s) are green whileKYMR’s FA Score has 0 green FA rating(s).

  • JANX’s FA Score: 0 green, 5 red.
  • KYMR’s FA Score: 0 green, 5 red.
According to our system of comparison, JANX is a better buy in the long-term than KYMR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

JANX’s TA Score shows that 4 TA indicator(s) are bullish while KYMR’s TA Score has 4 bullish TA indicator(s).

  • JANX’s TA Score: 4 bullish, 4 bearish.
  • KYMR’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both JANX and KYMR are a good buy in the short-term.

Price Growth

JANX (@Biotechnology) experienced а +0.52% price change this week, while KYMR (@Biotechnology) price change was +1.59% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.17%. For the same industry, the average monthly price growth was -5.68%, and the average quarterly price growth was +64.91%.

Reported Earning Dates

JANX is expected to report earnings on Mar 06, 2026.

KYMR is expected to report earnings on Feb 19, 2026.

Industries' Descriptions

@Biotechnology (-2.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($4.67B) has a higher market cap than JANX($1.75B). KYMR YTD gains are higher at: 60.017 vs. JANX (-45.798). JANX has higher annual earnings (EBITDA): -142.8M vs. KYMR (-267.03M). JANX has more cash in the bank: 996M vs. KYMR (665M). JANX has less debt than KYMR: JANX (22.2M) vs KYMR (85.7M). KYMR has higher revenues than JANX: KYMR (44.7M) vs JANX (439K).
JANXKYMRJANX / KYMR
Capitalization1.75B4.67B37%
EBITDA-142.8M-267.03M53%
Gain YTD-45.79860.017-76%
P/E RatioN/AN/A-
Revenue439K44.7M1%
Total Cash996M665M150%
Total Debt22.2M85.7M26%
TECHNICAL ANALYSIS
Technical Analysis
JANXKYMR
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
86%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 9 days ago
85%
Bullish Trend 6 days ago
84%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 29 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 6 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
JANX
Daily Signal:
Gain/Loss:
KYMR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
APDSX36.820.09
+0.25%
Artisan Small Cap Advisor
RMDCX3.33N/A
N/A
Virtus Silvant Mid-Cap Growth C
FSPSX60.27N/A
N/A
Fidelity International Index
BSGIX15.12N/A
N/A
Baird Small/Mid Cap Growth Institutional
TSRLX80.54N/A
N/A
Touchstone Large Cap Focused R6

JANX and

Correlation & Price change

A.I.dvisor indicates that over the last year, JANX has been loosely correlated with NUVL. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if JANX jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JANX
1D Price
Change %
JANX100%
+1.04%
NUVL - JANX
47%
Loosely correlated
-3.48%
APGE - JANX
43%
Loosely correlated
-1.42%
CGON - JANX
41%
Loosely correlated
+3.15%
SKYE - JANX
41%
Loosely correlated
-4.29%
KYMR - JANX
40%
Loosely correlated
+0.43%
More